Latest News of ABEO
Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO)
By Yahoo! Finance |
3 months ago
Institutional investors hold a significant stake in Abeona Therapeutics, influencing the stock's performance. Ownership structure reveals institutions own 39%, followed by hedge funds. Analysts and in...
ABEO Stock Price | Abeona Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
By MarketWatch |
3 months ago
Abeona Therapeutics is a biopharmaceutical company developing gene therapy for rare diseases. Their programs include treatments for recessive dystrophic epidermolysis bullosa and Sanfilippo syndromes....
Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)
By Yahoo! Finance |
4 months ago
Christine Silverstein, Director of Abeona Therapeutics Inc, sold 25,821 shares, now owning 62,063 shares. Abeona focuses on gene therapies for rare genetic diseases like EB-101 and ABO-102....